INTRODUCING THE N1 REGISTRY
A PROSPECTIVE, COMPREHENSIVE GENOMIC-CLINICAL OUTCOME DATABASE DEVELOPED TO BENEFIT ALL
CureOne has created a revolutionary registry that connects the highest quality standardized molecular testing with clinical outcomes. The data obtained by this registry currently does not exist. N1 fills a major hole in cancer research and is a monumental step forward in curing persistent diseases, like cancer.
“CureOne is filling a crucial gap in the advancement of cancer care. The only way we can do this is if we bring everyone together to focus on finding answers for patients.”
DANE J. DICKSON M.D.
CEO and Founder
WHAT OTHERS ARE SAYING
“Our collaboration with CureOne is consistent with Foundation Medicine’s approach to data sharing and data transparency, and reinforces our vision that progress in personalized cancer care can best be accelerated through a collaborative exchange of molecular information.”*
TROY COX, Chief Executive Officer
*Quote taken from the Foundation Medicine/CureOne Press Release.